[181 Pages Report] The global continuous manufacturing market is expected to reach USD 650.4 Million by 2022 from USD 348.5 Million in 2017, at a CAGR of 13.3%. The major drivers for the market include advantages of continuous manufacturing in pharmaceutical processes such as cost-effectiveness and improved efficiency of manufacturing, favorable regulatory environment, and support from regulatory authorities for the implementation of continuous manufacturing.
https://www.marketsandmarkets.com/Market-Reports/continuous-manufacturing-market-84747779.html
The report provides an overall understanding of the Continuous Manufacturing Market. In this report, the market is segmented on the basis of product, application, end user, and geography. The product segment includes integrated systems, semi-continuous systems, and controls. Among these product segments, the integrated systems segment is expected to account for the largest share of the Continuous Manufacturing market in 2017. The application segment includes Active Pharmaceutical Ingredient (API) manufacturing and end product manufacturing. The end user segment includes R&D departments and full-scale manufacturing companies. The geographic segments included in this report are North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=84747779
A combination of bottom-up and top-down approaches was used to calculate the Continuous Manufacturing market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.
Geographic analysis of the global continuous manufacturing industry reveals that the North American segment is expected to account for the largest share, owing to the need to reduce rising operational costs and eliminate the issues related to the inconsistent quality of pharmaceutical products produced through batch manufacturing and support from the FDA.
Major players in the Continuous Manufacturing market are GEA Group AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bosch Packaging Technology (Germany), Coperion GmbH (Germany), and Glatt GmbH (Germany).
Target Audience for this Report:
- Vendors/service providers
- Research institutes
- Pharmaceutical manufacturers
- Contract research organizations (CROs)
- Contract manufacturing organizations (CMOs)
The geographic segments in this report include North America, Europe, Asia-Pacific, and RoW. Of these, the North American segment is expected to account for the largest share of the market in 2017. This large share can primarily be attributed to the support from regulatory bodies, initiation by leading pharmaceutical companies, and the need for pharmaceutical manufacturers to reduce rising operational costs and eliminate issues related to the inconsistent quality of pharmaceutical products produced through batch manufacturing.
